{
  "docId": "019de515-fc5e-76ca-8883-dafdda1b8616",
  "docSlug": "fc6386684027a59abf9ad1908a49f4e4",
  "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
  "authorId": "nemaura-medical",
  "authorName": "Nemaura Medical",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 22,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de515-fc5e-76ca-8883-dafdda1b8616/8",
  "deckHref": "/decks/019de515-fc5e-76ca-8883-dafdda1b8616",
  "deckJsonHref": "/decks/019de515-fc5e-76ca-8883-dafdda1b8616.json",
  "deckAnchorHref": "/decks/019de515-fc5e-76ca-8883-dafdda1b8616#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.43,
        "w": 0.28,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "image",
      "text": null,
      "attrs": {},
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "531427a3-32e4-4804-b910-266cd92438a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.49,
        "w": 0.15,
        "x": 0.16,
        "y": 0.49
      },
      "kind": "image",
      "text": null,
      "attrs": {},
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91575db8-84a5-43a9-85d4-3b480c9dc8c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.73,
        "w": 0.639,
        "x": 0.327,
        "y": 0.19
      },
      "kind": "list",
      "text": "TARGET: Obtain FDA approval for sugarBEAT®\nTARGET: Scale-up manufacture to support sales in UK, Europe & and Middle East through licensees\nTARGET: Build market share in USA with employers and insurers, for the BEAT®diabetes and Miboko (non-medical) programs. Scaled-up Pilot programs in June 2023.\nTARGET: Launch sugarBEAT® ‘Direct-to-Consumer' in all major territories accepting CE approval as part of product registration; Discussions in multiple territories ongoing\nTARGET: Commercial exploitation of the metabolic health and wellbeing market using the sensors, initially targeting over 87 million people in the USA with pre-diabetes1",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "04a5d80a-6dd6-42e8-8c71-be45843ed727",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.44,
        "x": 0.327,
        "y": 0.066
      },
      "kind": "title",
      "text": "Future targets..",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b819b2c6-ce06-4c33-9ed6-adeabe63c670",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 6,
      "beatId": "cc9fa56d-e51f-4455-9689-fcbc635b4dbd",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "slides 6-14 demonstrate the product and its positioning",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "99db37b7-60e2-4606-9848-cb0be6231906",
      "evidence": "slides 5-14 explain the solution and its advantages",
      "position": 1,
      "objective": "How does Nemaura Medical's solution work and what are its benefits?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}